Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines has been on the rise in recent years, and the D-A-CH region is no exception.
Customer preferences: In the D-A-CH region, customers are increasingly interested in vaccines that offer protection against multiple diseases. Combination vaccines, which offer immunity against two or more diseases, are becoming more popular. Additionally, there is a growing demand for vaccines that can be administered orally or nasally, rather than through injections.
Trends in the market: One of the main trends in the D-A-CH vaccines market is the increasing focus on preventative healthcare. Governments and healthcare providers are investing more in vaccination programs to prevent the spread of diseases and reduce healthcare costs in the long run. Another trend is the growing importance of emerging markets, particularly in Asia and Africa, which are driving demand for vaccines.
Local special circumstances: Germany, Switzerland, and Austria have different vaccination policies and regulations. In Germany, vaccinations are not mandatory, but there is a strong recommendation for children to receive certain vaccinations. In Switzerland, vaccinations are also not mandatory, but there is a national vaccination program in place. In Austria, vaccinations are mandatory for certain diseases, including measles, mumps, and rubella. These differences in policies and regulations can impact the demand for vaccines in each country.
Underlying macroeconomic factors: The D-A-CH region has a strong economy and a high standard of living, which means that customers are willing to pay for high-quality healthcare products, including vaccines. Additionally, the region has an aging population, which is driving demand for vaccines that protect against diseases such as influenza and pneumonia. Finally, the COVID-19 pandemic has increased awareness of the importance of vaccines and may lead to increased demand for vaccines in the future.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
